References
- Kastelein JJP, Akdim F, Stroes ESG et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N. Engl. J. Med.358, 1431–1443 (2008).
- Smilde TJ, van Wissen S, Awollersheim H, Trip MD, Kastelein JJP, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial. Lancet357, 577–581 (2001).
- Nissen SE, Nicholls SJ, Wolski K et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with Type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA299, 1561–1573 (2008).
- Mazzone T, Meyer PM, Feinstein SB et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in Type 2 diabetes: a randomized trial. JAMA296, 2572–2581 (2006).
- Dormandy JA, Charbonnel B, Eckland DJA et al. Secondary prevention of macrovascular events in patients with Type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet366, 1279–1289 (2005).
- Bertrand OF, Poirier P, Rinfret S et al. Results of a multicenter randomized double-blind placebo controlled study to assess the benefit and safety of rosiglitazone in preventing atherosclerosis progression after coronary artery bypass surgery in Type 2 diabetes. Presented at: American College of Cardiology 57th Annual Scientific Session. Chicago, IL, USA, 29 March–1 April 2008.
- Nissen SE, Nicholls SJ, Wolski K et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA299, 1547–1560 (2008).
- Gueyffier F, Bulpitt C, Boissel J-P et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet353, 793–796 (1999).
- Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. DOI: NEJMoa0801369 (2008) (Epub ahead of print).
- Jamerson KA, Bakris GL, Wun CC et al. Rationale and design of the Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension. Am. J. Hypertens.17, 793–801 (2004).
- Yusuf S, Sleight P, Anderson C et al. Telmisartan, ramipril, or both in patients at high risk for vascular events: for the ONTARGET investigators. N. Engl. J. Med.358, 1547–1559 (2008).
- Bardy GH, Lee KL, Mark DB et al. Home use of automated external defibrillators for sudden cardiac arrest. N. Engl. J. Med. DOI: 10.1056/NEJMoa0801651 (2008) (Epub ahead of print).